Drugs / EPC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03726814 | Dec 2018 | ischemic stroke | Allife Medical Science and Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03726814 ↗ |
| Modality | Cell therapy | “Human Peripheral Blood Derived Induced EPCs” NCT03726814 ↗ |
| Route | Other | “Brain injection EPC” NCT03726814 ↗ |